News & Perspective

Mar 27, 2008

Mar 27, 2008

Swiss find H5N1 in wild duck; India has new outbreak

(CIDRAP News) – Animal health officials in Switzerland today said samples from an asymptomatic duck were positive for H5N1 avian influenza, as officials in India announced a poultry outbreak in another district in West Bengal state.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 06, 2007

Nov 06, 2007

Report says chikungunya could return in Europe next spring

(CIDRAP News) – Health experts who investigated Europe's first chikungunya outbreak involving transmission by local mosquitoes recently reported that cases could occur again next spring unless vigorous mosquito surveillance and eradication measures are used to control the disease in Italyand prevent its spread to other parts of Europe.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Sep 10, 2007

Sep 10, 2007

Chikungunya fever gains foothold in Europe

(CIDRAP News) – A recent outbreak of the debilitating tropical disease known as chikungunya fever in northern Italy apparently marks the mosquito-borne infection's first foothold in Europe, according to European health authorities.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Jun 08, 2007

Jun 08, 2007

Human antibodies protect mice from H5N1 avian flu

(CIDRAP News) – Antibodies gleaned from four Vietnamese patients who survived H5N1 avian influenza were used successfully to prevent and treat H5N1 infection in mice, suggesting that the same approach might be useful in humans, according to a recent report by an international team of researchers.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Nov 02, 2006

Nov 02, 2006

WHO report calls H5N1 vaccine stockpiling premature

(CIDRAP News) – A group of influenza experts convened by the World Health Organization cautioned today that governments shouldn't stockpile "pre-pandemic" H5N1 influenza vaccines now, because too little is known about the requirements for an effective vaccine.

Oct 12, 2006

Oct 12, 2006

FAO launches disease crisis center

(CIDRAP News) – To speed emergency responses to avian influenza and other animal and plant diseases, the United Nations Food and Agriculture Organization (FAO) inaugurated a new crisis management center (CMC) at its Rome headquarters today.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»